VK2735
From Wikipedia, the free encyclopedia
VK2735 is a dual agonist of the GLP-1 receptor and GIP receptor, with a similar mechanism of action as tirzepatide, which acts on the same receptors. Both injectable and oral forms are being developed by Viking Therapeutics.[1][2][3]